D-0625-2026 Class I Ongoing

Recalled by CareFusion 213, LLC — El Paso, TX

FDA drug recall D-0625-2026 was initiated by CareFusion 213, LLC on May 28, 2026 and is designated Class I. Reason for recall: Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area. The recall status is ongoing. Affected quantity: 178,000 applicators.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
May 28, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
178,000 applicators

Product description

BD ChloraPrep FREPP Clear,(2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) 1.5 mL Applicator, 20 Applicators, Sterile Solution, Care Fusion 213, LLC, El Paso, TX 79912, subsidiary of Beckton, Dickinson and Co., NDC 54365-400-30.

Reason for recall

Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.

Distribution pattern

Nationwide inthe USA, as well as other foreign distribution.

Code information

Lot # 4073005, Exp 03/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0625-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0625-2026. Report a data issue: hello@regdatalab.com.